RedHill Biopharma (RDHL) Interest Coverage Ratio Growth (3y) (2015 - 2023)
RedHill Biopharma (RDHL) Interest Coverage Ratio Growth (3y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 101.33% |
| Mar 31, 2023 | -50.97% |
| Dec 31, 2022 | -35.45% |
| Sep 30, 2022 | 26.09% |
| Jun 30, 2022 | 26.72% |
| Mar 31, 2022 | -21.92% |
| Dec 31, 2021 | -255.62% |
| Sep 30, 2021 | -40.17% |
| Jun 30, 2021 | 1.70% |
| Mar 31, 2021 | -69.53% |
| Dec 31, 2020 | -87.49% |
| Sep 30, 2020 | -25.33% |
| Jun 30, 2020 | -87.91% |
| Mar 31, 2020 | -38.09% |
| Dec 31, 2019 | 35.80% |
| Sep 30, 2019 | -75.29% |
| Jun 30, 2019 | -30.21% |
| Mar 31, 2019 | -88.52% |
| Dec 31, 2018 | -26.45% |
| Sep 30, 2018 | -19.07% |